| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |